Novavax (NVAX) Return on Sales [ROS] (2010 - 2026)
Novavax's Return on Sales [ROS] came in at -96.84% for Q2 2026, down 139.09 percentage points from 42.25% a year earlier and down 85.78 percentage points from the prior quarter.
Powered by 
Analysis
Novavax (NVAX) Return on Sales [ROS] (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Novavax reported Return on Sales [ROS] of -56.58%, down 89.16 percentage points year-over-year; for FY2025, it was 40.30%, up 76.79 percentage points from FY2024.
- Return on Sales [ROS] carries a five-year change of +127.92 percentage points (FY2020 to FY2025).
- Going back by year, Return on Sales [ROS] was -36.49% in FY2024 (+21.10 pp), -57.59% in FY2023 (-25.06 pp), -32.53% in FY2022 (+114.60 pp) and -147.13% in FY2021 (-59.51 pp).
- The five-year range for quarterly Return on Sales [ROS] is -386.37% (Q1 2023) to 77.33% (Q1 2025).
- Year-over-year, Return on Sales [ROS] increased in three of the last eight quarters, with an average year-over-year change of -13.15 percentage points.
- The fastest year-over-year change in Return on Sales [ROS] over five years came in Q4 2022 (a gain of 303.04 percentage points), and the weakest in Q1 2023 (a drop of 416.10 percentage points).
- Business Quant data shows NVAX's Return on Sales [ROS] at -11.06% (Q1 2026), 9.67% (Q4 2025) and -252.70% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Novavax | 1.72 Bn | -1.28 Bn | 42.45 Mn | -96.84% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -96.84% |
| Mar 31, 2026 | -11.06% |
| Dec 31, 2025 | 9.67% |
| Sep 30, 2025 | -252.70% |
| Jun 30, 2025 | 42.25% |
| Mar 31, 2025 | 77.33% |
| Dec 31, 2024 | -148.43% |
| Sep 30, 2024 | -158.58% |
| Jun 30, 2024 | 38.75% |
| Mar 31, 2024 | -154.31% |
| Dec 31, 2023 | -63.01% |
| Sep 30, 2023 | -67.19% |
| Jun 30, 2023 | 13.07% |
| Mar 31, 2023 | -386.37% |
| Dec 31, 2022 | -68.24% |
| Sep 30, 2022 | -17.31% |
| Jun 30, 2022 | -259.76% |
| Mar 31, 2022 | 29.73% |
| Dec 31, 2021 | -371.27% |
| Sep 30, 2021 | -171.74% |
API Access
Novavax Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=NVAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "NVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=NVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();